Quote:
|
Originally Posted by demeurj |
Something similar to androderm would be great if it weren't at such a low dosage rate. All it would take is the right people recognizing the market and who also have the resources to put out the same thing in a higher dosage version. All the pertinent info is out there and available as far as the technology goes. Since all of the
AAS are so similar structurally, there's no reason not to think that the exact same methods could be used for each
AAS. It's really not that far-fetched. It'd be worth it for someone to at least look into it.